Figure 4
Figure 4. Effects of antisense knockdown of ANTXR2, BAMBI, DCBLD2, ESAM, and LRRC32 zebrafish orthologs on thrombus formation. TTA (A) and TSA (B) in the MO-injected fish were compared with that of their matched sibling controls. Each experiment is representative of more than 4 experiments, including similar numbers for both groups, using 2 nonoverlapping MOs. Zebrafish larvae were injected with the following MOs: 2 ng ANTXR2 atg1, 2 ng ANTXR2 sp1, 2 ng BAMBI atg1, 1 ng BAMBI sp1, 4 ng DCBLD2 atg1, 0.5 ng DCBLD2 sp1, 1 ng ESAM sp1, 12 ng ESAM sp2, 4 ng LRRC32 atg1, or 2 ng LRRC32 sp1. Statistical analyses were performed using an unpaired Student t test (*P < .05; **P < .005). (C) Results from all experiments and for each of the 2 MOs tested per gene were combined for TTA (□) and TSA () using Cox regression and linear mixed modeling, respectively, as described in “Statistical analysis of the thrombosis model” (*P < .05; **P < .005; ***P < .001). †TTA data for each DCBLD2 MO were significantly different and therefore were not combined. ††Results for TSA are applicable for esam sp1 only. Detailed P values for the combined and individual MO analysis are presented in Table 3.

Effects of antisense knockdown of ANTXR2, BAMBI, DCBLD2, ESAM, and LRRC32 zebrafish orthologs on thrombus formation. TTA (A) and TSA (B) in the MO-injected fish were compared with that of their matched sibling controls. Each experiment is representative of more than 4 experiments, including similar numbers for both groups, using 2 nonoverlapping MOs. Zebrafish larvae were injected with the following MOs: 2 ng ANTXR2 atg1, 2 ng ANTXR2 sp1, 2 ng BAMBI atg1, 1 ng BAMBI sp1, 4 ng DCBLD2 atg1, 0.5 ng DCBLD2 sp1, 1 ng ESAM sp1, 12 ng ESAM sp2, 4 ng LRRC32 atg1, or 2 ng LRRC32 sp1. Statistical analyses were performed using an unpaired Student t test (*P < .05; **P < .005). (C) Results from all experiments and for each of the 2 MOs tested per gene were combined for TTA (□) and TSA () using Cox regression and linear mixed modeling, respectively, as described in “Statistical analysis of the thrombosis model” (*P < .05; **P < .005; ***P < .001). †TTA data for each DCBLD2 MO were significantly different and therefore were not combined. ††Results for TSA are applicable for esam sp1 only. Detailed P values for the combined and individual MO analysis are presented in Table 3.

Close Modal

or Create an Account

Close Modal
Close Modal